annual operating expenses:
$141.76M-$23.21M(-14.07%)Summary
- As of today (September 15, 2025), AKBA annual total operating expenses is $141.76 million, with the most recent change of -$23.21 million (-14.07%) on December 31, 2024.
- During the last 3 years, AKBA annual operating expenses has fallen by -$181.80 million (-56.19%).
- AKBA annual operating expenses is now -70.22% below its all-time high of $475.94 million, reached on December 31, 2019.
Performance
AKBA Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$38.15M+$2.27M(+6.31%)Summary
- As of today (September 15, 2025), AKBA quarterly total operating expenses is $38.15 million, with the most recent change of +$2.27 million (+6.31%) on June 1, 2025.
- Over the past year, AKBA quarterly operating expenses has increased by +$3.22 million (+9.22%).
- AKBA quarterly operating expenses is now -73.14% below its all-time high of $142.04 million, reached on December 31, 2018.
Performance
AKBA quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AKBA Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.1% | +9.2% |
| 3 y3 years | -56.2% | -35.1% |
| 5 y5 years | -70.2% | -57.0% |
AKBA Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.2% | at low | -36.7% | +318.5% |
| 5 y | 5-year | -70.2% | at low | -57.0% | +318.5% |
| alltime | all time | -70.2% | +1563.3% | -73.1% | +1946.7% |
AKBA Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $38.15M(+6.3%) |
| Mar 2025 | - | $35.88M(-0.1%) |
| Dec 2024 | $141.76M(-14.1%) | $35.91M(+1.4%) |
| Sep 2024 | - | $35.41M(+1.4%) |
| Jun 2024 | - | $34.93M(-1.7%) |
| Mar 2024 | - | $35.52M(-0.7%) |
| Dec 2023 | $164.96M(-38.9%) | $35.76M(-2.0%) |
| Sep 2023 | - | $36.51M(-23.6%) |
| Jun 2023 | - | $47.78M(+6.4%) |
| Mar 2023 | - | $44.91M(+392.7%) |
| Dec 2022 | $270.11M(-16.5%) | $9.12M(-84.9%) |
| Sep 2022 | - | $60.24M(+2.6%) |
| Jun 2022 | - | $58.74M(-33.6%) |
| Mar 2022 | - | $88.43M(+18.0%) |
| Dec 2021 | $323.55M(-13.4%) | $74.95M(-14.1%) |
| Sep 2021 | - | $87.22M(+10.0%) |
| Jun 2021 | - | $79.26M(-3.5%) |
| Mar 2021 | - | $82.12M(+4.8%) |
| Dec 2020 | $373.77M(-21.5%) | $78.35M(-10.2%) |
| Sep 2020 | - | $87.22M(-1.8%) |
| Jun 2020 | - | $88.83M(-25.6%) |
| Mar 2020 | - | $119.36M(-5.5%) |
| Dec 2019 | $475.94M(+34.4%) | $126.27M(+15.2%) |
| Sep 2019 | - | $109.62M(-11.6%) |
| Jun 2019 | - | $123.96M(+6.0%) |
| Mar 2019 | - | $116.94M(-17.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $354.14M(+37.6%) | $142.04M(+410.1%) |
| Sep 2018 | - | $27.84M(-21.9%) |
| Jun 2018 | - | $35.66M(+45.6%) |
| Mar 2018 | - | $24.50M(-67.7%) |
| Dec 2017 | $257.28M(+89.2%) | $75.75M(+213.3%) |
| Sep 2017 | - | $24.18M(+9.2%) |
| Jun 2017 | - | $22.14M(-50.8%) |
| Mar 2017 | - | $44.97M(+18.2%) |
| Dec 2016 | $135.96M(+122.5%) | $38.04M(+5.4%) |
| Sep 2016 | - | $36.09M(-0.1%) |
| Jun 2016 | - | $36.14M(+41.1%) |
| Mar 2016 | - | $25.61M(+28.2%) |
| Dec 2015 | $61.12M(+63.2%) | $19.98M(+2.1%) |
| Sep 2015 | - | $19.57M(+81.9%) |
| Jun 2015 | - | $10.76M(-0.4%) |
| Mar 2015 | - | $10.81M(+2.0%) |
| Dec 2014 | $37.45M(+135.1%) | $10.59M(+10.7%) |
| Sep 2014 | - | $9.57M(+22.3%) |
| Jun 2014 | - | $7.83M(-18.3%) |
| Mar 2014 | - | $9.58M(+54.5%) |
| Dec 2013 | $15.93M(+86.9%) | $6.20M(+53.7%) |
| Sep 2013 | - | $4.03M(+29.3%) |
| Jun 2013 | - | $3.12M(+21.1%) |
| Mar 2013 | - | $2.58M(+38.2%) |
| Dec 2012 | $8.52M(-45.0%) | - |
| Dec 2012 | - | $1.86M |
| Dec 2011 | $15.50M | - |
FAQ
- What is Akebia Therapeutics, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Akebia Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of AKBA is $141.76M
What is the all time high annual operating expenses for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual total operating expenses is $475.94M
What is Akebia Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, AKBA annual total operating expenses has changed by -$23.21M (-14.07%)
What is Akebia Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of AKBA is $38.15M
What is the all time high quarterly operating expenses for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly total operating expenses is $142.04M
What is Akebia Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, AKBA quarterly total operating expenses has changed by +$3.22M (+9.22%)